FCN2 and cholangiocarcinoma: Furthermore, ficolin-2 (FCN2), inter-α-trypsin inhibitor heavy chain H4 (ITIH4) and fibrinogen γ chain (FIBG) provided high diagnostic values for the differential diagnosis of patients with early stage CCA and PSC, being superior diagnostic biomarkers than CA19-9.